Ignite Creation Date:
2024-05-06 @ 7:16 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02501668
Status:
COMPLETED
Last Update Posted:
2015-07-17
First Post:
2015-07-11
Brief Title:
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
Sponsor:
Keimyung University Dongsan Medical Center
Organization:
Keimyung University Dongsan Medical Center
Study Overview
Official Title:
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will evaluate the prevalence of lung cancer associated with interstitial lung disease ILD and idiopathic pulmonary fibrosis IPF utilizing the Korean Health Insurance Review and Assessment Service HIRA database spanning the period from January 2011 to December 2011 The database HIRA-NPS-2011-0001 was based on random sampling of outpatients from whole population Patients with ILDs IPF connective tissue disorder CTD and COPD were identified based on the International Classification of Disease-10 ICD-10 diagnostic codes
Detailed Description:
The epidemiology of lung cancer related to interstitial lung disease ILD with or without with connective tissue disease CTD as well as idiopathic pulmonary fibrosis IPF has not been well established yet Interstitial lung disease has a potential to develop lung cancer in the name of scar cancer The investigators aimed to explore prevalence of lung cancer in patients with ILD with or without CTD and IPF in comparison with chronic obstructive pulmonary disorder COPD
The investigators will evaluate the prevalence of lung cancer associated with ILD and IPF utilizing the Korean Health Insurance Review and Assessment Service HIRA database spanning the period from January 2011 to December 2011 The database HIRA-NPS-2011-0001 was based on random sampling of outpatients from whole population The sample cases are total 1375842 Among them 670258 cases age 40 were evaluated Patients with ILDs IPF CTD and COPD will be identified based on the International Classification of Disease-10 ICD-10 diagnostic codes
The investigators will evaluate the prevalence of lung cancer associated with ILD and IPF utilizing the Korean Health Insurance Review and Assessment Service HIRA database spanning the period from January 2011 to December 2011 The database HIRA-NPS-2011-0001 was based on random sampling of outpatients from whole population The sample cases are total 1375842 Among them 670258 cases age 40 were evaluated Patients with ILDs IPF CTD and COPD will be identified based on the International Classification of Disease-10 ICD-10 diagnostic codes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None